CLARISSE E.
- Country
- France
- Department
- chirurgie digestive
Research Overview
- Phase II Multicenter Randomized Trial of PIPAC and Systemic Chemotherapy Versus Systemic Chemotherapy Alone in First-Line Treatment of Malignant Peritoneal Mesothelioma
- Evaluation of Systemic Chemotherapy and Targeted Therapy with or without PIPAC in Advanced Colorectal Peritoneal Metastases: A Phase II Randomized Trial
- Phase III Randomized Trial of Neoadjuvant CAPOX or FOLFOX Chemotherapy in Obstructive Colon Cancer Post-Colostomy for Curative Therapeutic Sequence Evaluation
Data & Insights
Has run more than one trial at 21 of 60 partner sites.
Specializations
Mesothelioma Research
The investigator specializes in treating malignant pleural and peritoneal mesothelioma, with particular focus on developing maintenance therapies following platinum-based chemotherapy. Their work encompasses innovative approaches combining systemic chemotherapy with localized treatments.
- Advanced Pleural Mesothelioma Management
- Peritoneal Mesothelioma Treatment Strategies
- Maintenance Therapy Development
Peritoneal Oncology
Focuses on advancing treatment methods for peritoneal metastases, particularly in colorectal and ovarian cancers. The investigator explores the application of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with systemic treatments.
- Colorectal Cancer Peritoneal Metastases
- Advanced Ovarian Cancer Treatment
- Intraperitoneal Chemotherapy Techniques
Surgical Oncology
Specializes in cytoreductive surgery and innovative perioperative approaches for gastrointestinal cancers. The investigator studies advanced surgical techniques including hyperthermic intraperitoneal chemotherapy (HIPEC) and management of obstructive colon cancer.
- Neoadjuvant Treatment Strategies
- Surgical Management of Ovarian Cancer
- Emergency Oncological Surgery
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.